AveXis receives positive CHMP opinion for Zolgensma®, the only gene therapy for spinal muscular atrophy (SMA)

NEXT STORY
Novartis Cosentyx® gains positive CHMP opinion for new indication in the axial spondyloarthritis spectrum
PREV STORY
Global Biomedical Temperature Sensors Market to 2025 – Featuring TE Connectivity, Amphenol Advanced Sensors & Smiths Medical Among Others
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

OV – First prostate cancer patient included in Oncology Venture’s Phase 2 study of Irofulven for personalized treatment

Hoersholm, Denmark, October 18, 2018 - Oncology Venture A/S (Nasdaq First North Stockholm: OV.ST) ...

author_avatar
NASDAQ Market News

Amgen, Cytokinetics and Servier Announce Topline Results From GALACTIC-HF, a Phase 3 Trial of Omecamtiv Mecarbil in Patients With Heart Failure

author_avatar
NASDAQ Market News

Aileron Therapeutics to Host KOL Virtual Investor Event Discussing Opportunity for New Paradigm to Protect Cancer Patients from Chemotherapy-Induced Toxicities

author_avatar
NASDAQ Market News